Literature DB >> 32570146

COVID-19 in Africa.

G L Quaglio1, W Preiser2, G Putoto3.   

Abstract

Entities:  

Year:  2020        PMID: 32570146      PMCID: PMC7245311          DOI: 10.1016/j.puhe.2020.05.030

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


× No keyword cloud information.
As reported in more detail in an article recently published on the European Science-Media Hub website, Africa, despite having the world's greatest infectious disease burden, has a weak epidemiological surveillance system. Even in Europe, with its more advanced information systems, the official data on the coronavirus disease 2019 (COVID-19) are controversial because of poor standardisation. The data on COVID-19 in several African countries are currently scarce and uncertain, which does not allow for an objective analysis of the present situation. Some evidence also shows that several African countries exert tight control over public data and information. The World Health Organization recently rebuked the Tanzanian government for refusing to share information on alleged Ebola cases, the country denying the existence of any such cases. Furthermore, it is not uncommon for journalists disclosing information on COVID-19 to be subject to intimidation by public authorities. Interpretation of the pandemic's trend in Africa should consider three major factors: the undernotification of cases, the slower development of the epidemic and a comparatively lower incidence to other continents. Previous epidemics were subject to catastrophic predictions (the AIDS epidemic in the 1980s–90s, the more recent Ebola epidemic), predictions which did not eventually occur. Therefore, caution should be exercised in regards to the extremely negative predictions of the present pandemic. In health emergencies (especially epidemics), one of the most frequent risks in Africa is the suspension of essential prevention and treatment health services. The new SARS-CoV-2 emergency threatens to absorb resources destined for other preventable disease conditions, which – unlike COVID-19 – have known therapies: common paediatric infectious diseases, obstetric complications, vaccinations campaigns, etc. Avoidable morbidity and mortality of common diseases could therefore inflict more damage and claim more victims than the epidemic itself, as was the case in the recent Ebola epidemic. , Aid and, more importantly, other forms of sustainable assistance that would alter African socioeconomic trajectories – if and when they will be sent in the difficult times we are facing – will have to seriously consider the health systems. Finally, in Africa, particularly in the sub-Saharan region, there are no nation-wide health systems capable of enduring a wave of patients suffering acute respiratory failure. The massive and short-term intensive care requiring assisted breathing and other organ-failure support would be very challenging. As in Europe, and likely on a greater scale, any epidemic pressure will have to be addressed with home care under supervised self-medication. Large-scale diagnostics will not be affordable, and so it will be necessary to prioritise triage based on clinical case definition or presumptive diagnosis. ,

Disclaimer

The views expressed in this publication are the sole responsibility of the authors and do not necessarily reflect the views of the affiliated organizations.
  4 in total

1.  Managing COVID-19 in Low- and Middle-Income Countries.

Authors:  Joost Hopman; Benedetta Allegranzi; Shaheen Mehtar
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

2.  Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis.

Authors:  Patrick G T Walker; Michael T White; Jamie T Griffin; Alison Reynolds; Neil M Ferguson; Azra C Ghani
Journal:  Lancet Infect Dis       Date:  2015-04-23       Impact factor: 25.071

3.  Impact of Ebola outbreak on reproductive health services in a rural district of Sierra Leone: a prospective observational study.

Authors:  Gianluca Quaglio; Francesca Tognon; Livio Finos; David Bome; Santigie Sesay; Atiba Kebbie; Francesco Di Gennaro; Bienvenu Salim Camara; Claudia Marotta; Vincenzo Pisani; Zainab Bangura; Damiano Pizzol; Annalisa Saracino; Walter Mazzucco; Susan Jones; Giovanni Putoto
Journal:  BMJ Open       Date:  2019-09-04       Impact factor: 2.692

4.  Limiting the spread of COVID-19 in Africa: one size mitigation strategies do not fit all countries.

Authors:  Shaheen Mehtar; Wolfgang Preiser; Ndèye Aissatou Lakhe; Abdoulaye Bousso; Jean-Jacques Muyembe TamFum; Oscar Kallay; Moussa Seydi; Alimuddin Zumla; Jean B Nachega
Journal:  Lancet Glob Health       Date:  2020-04-28       Impact factor: 26.763

  4 in total
  1 in total

Review 1.  Addressing Africa's pandemic puzzle: Perspectives on COVID-19 transmission and mortality in sub-Saharan Africa.

Authors:  Hassan H Musa; Taha H Musa; Idriss H Musa; Ibrahim H Musa; Alessia Ranciaro; Michael C Campbell
Journal:  Int J Infect Dis       Date:  2020-09-30       Impact factor: 3.623

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.